Caroline Baumal

Companies

• Apellis Pharmaceuticals, Inc.Chief Medical Officer Jan 5, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APApellis Pharmaceuticals, Inc.0 shares²May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Returned to company 29,696 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 12,723 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 8,888 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 26,396 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 26,396 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 41,250 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 41,250 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 86,525 shares of Apellis Pharmaceuticals, Inc.²
• Apr 29, 2026Gift 900 shares of Apellis Pharmaceuticals, Inc.³
• Jan 22, 2026Sold 2,797 shares at $21.77 of Apellis Pharmaceuticals, Inc.⁴
• Jan 20, 2026Sold 1,882 shares at $19.79 of Apellis Pharmaceuticals, Inc.⁵
• Jan 5, 2026Sold 3,020 shares at $25.53 of Apellis Pharmaceuticals, Inc.⁶
• Jan 21, 2025Granted 39,594 shares of Apellis Pharmaceuticals, Inc.⁷
• Jan 17, 2025Sold 1,853 shares at $29.96 of Apellis Pharmaceuticals, Inc.⁷
• Jan 6, 2025Sold 2,816 shares at $33.81 of Apellis Pharmaceuticals, Inc.⁸
• Jan 16, 2024Granted 25,445 shares of Apellis Pharmaceuticals, Inc.⁹
• Jan 4, 2024Sold 2,751 shares at $60.05 of Apellis Pharmaceuticals, Inc.¹⁰
• Jan 3, 2023Granted 35,549 shares of Apellis Pharmaceuticals, Inc.¹¹